GlassScriptPhysician profile
Torrey R Schmidt
NPI 1326339490
$15,966.03
in general payments reported to CMS, 2019-2025
13 companies · $6,264 in 2025
The $6,264 reported for 2025 was more than what 93% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $272 · 2020: $178 · 2021: $384 · 2022: $325 · 2023: $6,133 · 2024: $2,410 · 2025: $6,264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Travel and Lodging: $2,484 · Food and Beverage: $1,243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,080.60 |
| Travel and Lodging | $2,483.59 |
| Food and Beverage | $1,243.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $6,971.92 | 2019-2025 | General - Balloons, Avvigo Guidance System |
| Neptune Medical INC. | $6,080.60 | 2023 | |
| Ge Healthcare | $1,902.25 | 2024 | |
| Inari Medical, INC. | $529.93 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Bard Peripheral Vascular, INC. | $180.17 | 2020-2021 | |
| Cardiovascular Systems INC. | $131.33 | 2022 | |
| Abbott Laboratories | $59.45 | 2020-2025 | Cardiomems, Xience Sierra |
| Philips North America LLC | $59.30 | 2024 | (P77) Azurion 7 M20 |
| Medtronic, INC. | $25.25 | 2023 | Onyx Frontier |
| Janssen Pharmaceuticals, INC | $13.85 | 2019 | |
| Chiesi USA, INC. | $11.98 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Torrey Schmidt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.